Functional IL18 polymorphism and susceptibility to Chronic Chagas Disease

Cytokine

Volumn 73, Issue 1, 2015, Pages 79-83

  Nogueira, Luciana Gabriel ^a,b   Frade, Amanda Farage ^a,b   Ianni, Barbara Maria ^a   Laugier, Laurie ^c   Pissetti, Cristina Wide ^d   Cabantous, Sandrine ^c   Baron, Monique ^a,b   de Lima Peixoto, Gisele ^a   de Melo Borges, Ariana ^d   Donadi, Eduardo ^a   Marin Neto, José A ^a   Schmidt, André ^a   Dias, Fabrício ^a   Saba, Bruno ^e   Wang, Hui Tzu Lin ^e   Fragata, Abilio ^e   Sampaio, Marcelo ^e   Hirata, Mario Hiroyuki ^e   Buck, Paula ^a   Mady, Charles ^a   Martinelli, Martino ^a   Lensi, Mariana ^a   Siqueira, Sergio Freitas ^a   Pereira, Alexandre Costa ^a   Rodrigues, Virmondes ^d   Kalil, Jorge ^a,b   Chevillard, Christophe ^c   Cunha Neto, Edecio ^a,b   more..

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Institute of Investigation in Immunology iii   (Brazil)

^c Aix Marseille university   (France)

^d FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^e INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

Author keywords

Cardiomyopathy; Chagas; IL18; Polymorphism; Severity

Indexed keywords

INTERLEUKIN 18;

ARTICLE; CHAGAS DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART VENTRICLE FUNCTION; HUMAN; IL18 GENE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; CHRONIC DISEASE; GENETIC PREDISPOSITION; GENETICS; HEART STROKE VOLUME; PATHOPHYSIOLOGY;

TRYPANOSOMA CRUZI;

CASE-CONTROL STUDIES; CHAGAS CARDIOMYOPATHY; CHRONIC DISEASE; COHORT STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-18; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; STROKE VOLUME;

EID: 84924059269     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.01.037     Document Type: Article

References (56)

1. Schofield C.J., Jannin J., Salvatella R. The future of Chagas disease control. Trends Parasitol 2006, 22(12):583-588.
2. Kirchhoff L.V., Weiss L.M., Wittner M., Tanowitz H.B. Parasitic diseases of the heart. Front Biosci 2004, 9:706-723.
3. Coura J.R. Chagas disease: what is known and what is needed - a background article. Mem Inst Oswaldo Cruz 2007, 102(Suppl 1):113-122.
4. Higuchi M.L., De Morais C.F., Pereira Barreto A.C., Lopes E.A., Stolf N., Bellotti G., et al. The role of active myocarditis in the development of heart failure in chronic Chagas' disease: a study based on endomyocardial biopsies. Clin Cardiol 1987, 10(11):665-670.
5. Milei J., Storino R., Fernandez Alonso G., Beigelman R., Vanzulli S., Ferrans V.J. Endomyocardial biopsies in chronic chagasic cardiomyopathy. Immunohistochemical and ultrastructural findings. Cardiology 1992, 80(5-6):424-437.
6. Higuchi Mde L., Gutierrez P.S., Aiello V.D., Palomino S., Bocchi E., Kalil J., et al. Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Arch A Pathol Anat Histopathol 1993, 423(3):157-160.
7. Abel L.C., Rizzo L.V., Ianni B., Albuquerque F., Bacal F., Carrara D., et al. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J Autoimmun 2001, 17(1):99-107.
8. Gomes J.A., Bahia-Oliveira L.M., Rocha M.O., Martins-Filho O.A., Gazzinelli G., Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun 2003, 71(3):1185-1193.
9. Reis D.D., Jones E.M., Tostes S., Lopes E.R., Chapadeiro E., Gazzinelli G., et al. Expression of major histocompatibility complex antigens and adhesion molecules in hearts of patients with chronic Chagas' disease. Am J Trop Med Hyg 1993, 49(2):192-200.
10. Reis M.M., Higuchi Mde L., Benvenuti L.A., Aiello V.D., Gutierrez P.S., Bellotti G., et al. An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. Clin Immunol Immunopathol 1997, 83(2):165-172.
11. Fonseca S.G., Reis M.M., Coelho V., Nogueira L.G., Monteiro S.M., Mairena E.C., et al. Locally produced survival cytokines IL-15 and IL-7 may be associated to the predominance of CD8+ T cells at heart lesions of human chronic Chagas disease cardiomyopathy. Scand J Immunol 2007, 66(2-3):362-371.
12. Nogueira L.G., Santos R.H., Fiorelli A.I., Mairena E.C., Benvenuti L.A., Bocchi E.A., et al. Myocardial gene expression of T-bet, GATA-3, Ror-gammat, FoxP3, and hallmark cytokines in chronic chagas disease cardiomyopathy: an essentially unopposed TH1-type response. Mediators Inflamm 2014, 2014:914326.
13. Muller U., Kohler G., Mossmann H., Schaub G.A., Alber G., Di Santo J.P., et al. IL-12-independent IFN-gamma production by T cells in experimental Chagas' disease is mediated by IL-18. J Immunol 2001, 167(6):3346-3353.
14. Dinarello C.A., Fantuzzi G. Interleukin-18 and host defense against infection. J Infect Dis 2003, 187(Suppl 2):S370-S384.
15. Nolan K.F., Greaves D.R., Waldmann H. The human interleukin 18 gene IL18 maps to 11q22.2-q22.3, closely linked to the DRD2 gene locus and distinct from mapped IDDM loci. Genomics 1998, 51(1):161-163.
16. Kruse S., Kuehr J., Moseler M., Kopp M.V., Kurz T., Deichmann K.A., et al. Polymorphisms in the IL18 gene are associated with specific sensitization to common allergens and allergic rhinitis. J Allergy Clin Immunol 2003, 111(1):117-122.
17. Thompson S.R., Humphries S.E. Interleukin-18 genetics and inflammatory disease susceptibility. Genes Immun 2007, 8(2):91-99.
18. Zicker F., Smith P.G., Netto J.C., Oliveira R.M., Zicker E.M. Physical activity, opportunity for reinfection, and sibling history of heart disease as risk factors for Chagas' cardiopathy. Am J Trop Med Hyg 1990, 43(5):498-505.
19. Llop E., Rothhammer F., Acuna M., Apt W. HLA antigens in cardiomyopathic Chilean chagasics. Am J Hum Genet 1988, 43(5):770-773.
20. Llop E., Rothhammer F., Acuna M., Apt W., Arribada A. HLA antigens in Chagas cardiomyopathy: new evidence based on a case-control study. Rev Med Chil 1991, 119(6):633-636.
21. Fernandez-Mestre M.T., Layrisse Z., Montagnani S., Acquatella H., Catalioti F., Matos M., et al. Influence of the HLA class II polymorphism in chronic Chagas' disease. Parasite Immunol 1998, 20(4):197-203.
22. Layrisse Z., Fernandez M.T., Montagnani S., Matos M., Balbas O., Herrera F., et al. HLA-C(*)03 is a risk factor for cardiomyopathy in Chagas disease. Hum Immunol 2000, 61(9):925-929.
23. Deghaide N.H., Dantas R.O., Donadi E.A. HLA class I and II profiles of patients presenting with Chagas' disease. Dig Dis Sci 1998, 43(2):246-252.
24. Colorado I.A., Acquatella H., Catalioti F., Fernandez M.T., Layrisse Z. HLA class II DRB1, DQB1, DPB1 polymorphism and cardiomyopathy due to Trypanosoma cruzi chronic infection. Hum Immunol 2000, 61(3):320-325.
25. Rodriguez-Perez J.M., Cruz-Robles D., Hernandez-Pacheco G., Perez-Hernandez N., Murguia L.E., Granados J., et al. Tumor necrosis factor-alpha promoter polymorphism in Mexican patients with Chagas' disease. Immunol Lett 2005, 98(1):97-102.
26. Campelo V., Dantas R.O., Simoes R.T., Mendes-Junior C.T., Sousa S.M., Simoes A.L., et al. TNF microsatellite alleles in Brazilian Chagasic patients. Dig Dis Sci 2007, 52(12):3334-3339.
27. Drigo S.A., Cunha-Neto E., Ianni B., Cardoso M.R., Braga P.E., Fae K.C., et al. TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients. Microbes Infect 2006, 8(3):598-603.
28. Beraun Y., Nieto A., Collado M.D., Gonzalez A., Martin J. Polymorphisms at tumor necrosis factor (TNF) loci are not associated with Chagas' disease. Tissue Antigens 1998, 52(1):81-83.
29. Drigo S.A., Cunha-Neto E., Ianni B., Mady C., Fae K.C., Buck P., et al. Lack of association of tumor necrosis factor-alpha polymorphisms with Chagas disease in Brazilian patients. Immunol Lett 2007, 108(1):109-111.
30. Florez O., Martin J., Gonzalez C.I. Interleukin 4, interleukin 4 receptor-alpha and interleukin 10 gene polymorphisms in Chagas disease. Parasite Immunol 2011, 33(9):506-511.
31. Cruz-Robles D., Chavez-Gonzalez J.P., Cavazos-Quero M.M., Perez-Mendez O., Reyes P.A., Vargas-Alarcon G. Association between IL-1B and IL-1RN gene polymorphisms and Chagas' disease development susceptibility. Immunol Invest 2009, 38(3-4):231-239.
32. Costa G.C., da Costa Rocha M.O., Moreira P.R., Menezes C.A., Silva M.R., Gollob K.J., et al. Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. J Infect Dis 2009, 199(3):451-454.
33. Moreno M., Silva E.L., Ramirez L.E., Palacio L.G., Rivera D., Arcos-Burgos M. Chagas' disease susceptibility/resistance. Linkage disequilibrium analysis suggests epistasis between major histocompatibility complex and interleukin-10. Tissue Antigens 2004, 64(1):18-24.
34. Zafra G., Morillo C., Martin J., Gonzalez A., Gonzalez C.I. Polymorphism in the 3' UTR of the IL12B gene is associated with Chagas' disease cardiomyopathy. Microbes Infect 2007, 9(9):1049-1052.
35. Ramasawmy R., Cunha-Neto E., Fae K.C., Borba S.C., Teixeira P.C., Ferreira S.C., et al. Heterozygosity for the S180L variant of MAL/TIRAP, a gene expressing an adaptor protein in the Toll-like receptor pathway, is associated with lower risk of developing chronic Chagas cardiomyopathy. J Infect Dis 2009, 199(12):1838-1845.
36. Ramasawmy R., Cunha-Neto E., Fae K.C., Martello F.G., Muller N.G., Cavalcanti V.L., et al. The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human chagas disease. Clin Infect Dis 2006, 43(3):305-311.
37. Ramasawmy R., Cunha-Neto E., Fae K.C., Muller N.G., Cavalcanti V.L., Drigo S.A., et al. BAT1, a putative anti-inflammatory gene, is associated with chronic Chagas cardiomyopathy. J Infect Dis 2006, 193(10):1394-1399.
38. Ramasawmy R., Fae K.C., Cunha-Neto E., Muller N.G., Cavalcanti V.L., Ferreira R.C., et al. Polymorphisms in the gene for lymphotoxin-alpha predispose to chronic Chagas cardiomyopathy. J Infect Dis 2007, 196(12):1836-1843.
39. Pissetti C.W., de Oliveira R.F., Correia D., Nascentes G.A., Llaguno M.M., Rodrigues V. Association between the lymphotoxin-alpha gene polymorphism and chagasic cardiopathy. J Interferon Cytokine Res 2013, 33(3):130-135.
40. Ramasawmy R., Fae K.C., Cunha-Neto E., Borba S.C., Ianni B., Mady C., et al. Variants in the promoter region of IKBL/NFKBIL1 gene may mark susceptibility to the development of chronic Chagas' cardiomyopathy among Trypanosoma cruzi-infected individuals. Mol Immunol 2008, 45(1):283-288.
41. Calzada J.E., Nieto A., Beraun Y., Martin J. Chemokine receptor CCR5 polymorphisms and Chagas' disease cardiomyopathy. Tissue Antigens 2001, 58(3):154-158.
42. Fernandez-Mestre M.T., Montagnani S., Layrisse Z. Is the CCR5-59029-G/G genotype a protective factor for cardiomyopathy in Chagas disease?. Hum Immunol 2004, 65(7):725-728.
43. Torres O.A., Calzada J.E., Beraun Y., Morillo C.A., Gonzalez C.I., Gonzalez A., et al. Association of the macrophage migration inhibitory factor -173G/C polymorphism with Chagas disease. Hum Immunol 2009, 70(7):543-546.
44. Torres O.A., Calzada J.E., Beraun Y., Morillo C.A., Gonzalez A., Gonzalez C.I., et al. Role of the IFNG+874T/A polymorphism in Chagas disease in a Colombian population. Infect Genet Evol 2010, 10(5):682-685.
45. Cunha-Neto E., Coelho V., Guilherme L., Fiorelli A., Stolf N., Kalil J. Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. J Clin Invest 1996, 98(8):1709-1712.
46. Teixeira P.C., Frade A.F., Nogueira L.G., Kalil J., Chevillard C., Cunha-Neto E. Pathogenesis of Chagas disease cardiomyopathy. World J Clin Infect Dis 2012, 2(3):39-53.
47. Vasconcelos R.H., Montenegro S.M., Azevedo E.A., Gomes Y.M., Morais C.N. Genetic susceptibility to chronic Chagas disease: an overview of single nucleotide polymorphisms of cytokine genes. Cytokine 2012, 59(2):203-208.
48. Cunha-Neto E., Nogueira L.G., Teixeira P.C., Ramasawmy R., Drigo S.A., Goldberg A.C., et al. Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy. Mem Inst Oswaldo Cruz 2009, 104(Suppl 1):252-258.
49. Bilate A.M., Cunha-Neto E. Chagas disease cardiomyopathy: current concepts of an old disease. Rev Inst Med Trop Sao Paulo 2008, 50(2):67-74.
50. Frade A.F., Teixeira P.C., Ianni B.M., Pissetti C.W., Saba B., Wang L.H., et al. Polymorphism in the alpha cardiac muscle actin 1 gene is associated to susceptibility to chronic inflammatory cardiomyopathy. PLoS ONE 2013, 8(12):e83446.
51. Jorge M.T., Macedo T.A., Janones R.S., Carizzi D.P., Heredia R.A., Acha R.E. Types of arrhythmia among cases of American trypanosomiasis, compared with those in other cardiology patients. Ann Trop Med Parasitol 2003, 97(2):139-148.
52. Frade A.F., Pissetti C.W., Ianni B.M., Saba B., Lin-Wang H.T., Nogueira L.G., et al. Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathways. BMC Infect Dis 2013, 13:587.
53. Cunha-Neto E., Dzau V.J., Allen P.D., Stamatiou D., Benvenutti L., Higuchi M.L., et al. Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. Am J Pathol 2005, 167(2):305-313.
54. Chandrasekar B., Valente A.J., Freeman G.L., Mahimainathan L., Mummidi S. Interleukin-18 induces human cardiac endothelial cell death via a novel signaling pathway involving NF-kappaB-dependent PTEN activation. Biochem Biophys Res Commun 2006, 339(3):956-963.
55. Reddy V.S., Harskamp R.E., van Ginkel M.W., Calhoon J., Baisden C.E., Kim I.S., et al. Interleukin-18 stimulates fibronectin expression in primary human cardiac fibroblasts via PI3K-Akt-dependent NF-kappaB activation. J Cell Physiol 2008, 215(3):697-707.
56. Nogueira L.G., Santos R.H., Ianni B.M., Fiorelli A.I., Mairena E.C., Benvenuti L.A., et al. Myocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10. PLoS Negl Trop Dis 2012, 6(10):e1867.